Identification Of High-risk Coronary Plaques By Multimodal Intravascular Imaging
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Da Yin, MD
Shenzhen People's Hospital
Principal Investigator - Hua Yan
Wuhan Asian Heart Hospital
Principal Investigator - Jie Deng, MD
Xi'an Jiaotong University Second Affiliated Hospital
Principal Investigator - Jun Jiang, MD
Second Affiliated Hospital, School of Medicine, Zhejiang University
Principal Investigator - Lei Song
Chinese Academy of Medical Sciences, Fuwai Hospital
Principal Investigator - Ning Yang, MD
Tianjin Chest Hospital
Principal Investigator - Wei Liu, MD
Beijing Jishuitan Hospital
Principal Investigator - Yining Yang, MD
People's Hospital of Xinjiang Uygur Autonomous Region
Principal Investigator - Yong Zeng, PD
Beijing Anzhen Hospital
Principal Investigator - Yun Dai Chen, MD, PHD
People's Liberation Army General Hospital
Study Chair - Yuquan He, MD
China-Japan Union Hospital, Jilin University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Shenzhen People'S Hospital
Shenzhen, Guandong, China
- Tongji Hospital Affiliated To Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
- Wuhan Asian Heart Hospital
Wuhan, Hubei, China
- China-Japan Union Hospital of Jilin University
Changchun, Jilin, China
- Xi'An Jiaotong University Second Affiliated Hospital
Xi'an, Shaanxi, China
- People'S Hospital of Xinjiang Uygur Autonomous Region
Ürümqi, Xinjiang Uygur Autonomous Region, China
- the Second Affiliated Hospital, Zhejiang University
Hangzhou, Zhejiang, China
- Beijing Anzhen Hospital, Capital Medical University
Beijing, China
- Beijing Jishuitan Hospital
Beijing, China
- Fuwai Hospital, Chinese Academy of Medical Sciences
Beijing, China
- People'S Liberation Army General Hospital
Beijing, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2024
- Primary completion
- 31 Dec 2027
- Completion
- 31 Dec 2031
- Last update posted
- 8 Nov 2024
- Registered enrollment
- 500
- Registry id
- NCT06681155
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.